MedTrace Logo

Acute Lower gastroIntestinal BleedIng (ALIBI Study) in Italy

NCT04364412 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1198

Last updated 2020-05-19

No results posted yet for this study

Summary

Unlike upper GI bleeding, for LGIB there is still a paucity of data on clinical presentation, patient characteristics, pathways of care and outcomes for LGIB patients. In-hospital mortality ranges from 1.2% to 8.8% (2-4), according to retrospective studies, but data from prospective series are still limited (5).

Present multicentre, prospective, observational study was designed to explore these areas, to assess variations in practice management and to identify factors associated with patient outcomes.

Conditions

  • Lower GI Bleeding

Sponsors & Collaborators

  • Valduce Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2020-05-18
Completion
2020-05-18

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04364412 on ClinicalTrials.gov